GIT1 and gastric cancer: Besides, in gastric cancer, Methyl-CpG binding protein 2 (MeCP2) facilitates cell proliferation and cell-cycle progression by activating MEK1/2-ERK1/2 signaling through GIT1 upregulation [25].